Global Health Ratios

Global Health Ltd Ratios

The Global Health Ltd Ratios page provides a complete fundamental analysis of Global Health Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Global Health Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Global Health Ltd (NSE: MEDANTA, BSE: 543654) is currently trading at ₹961.10, with a market capitalization of ₹258.51B. As a major player in the Health services sector and Hospital/Nursing management industry, Global Health Ltd remains a key stock for fundamental analysis using Global Health Ltd Ratios.

Global Health Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Global Health Ltd P/E ratio currently stands at 66.85, making it one of the most tracked metrics in Global Health Ltd Ratios.

Historically, the Global Health Ltd P/E ratio has shown strong fluctuations:

• 2024: 66.85
• 2023: 74.35
• 2022: 41.87
• 2021: 0
• 2020: 0

The decline in Global Health Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Global Health Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 9.50.

Historical P/B trend:

• 2024: 9.50
• 2023: 12.23
• 2022: 5.81
• 2021: 0

Global Health Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Global Health Ltd P/S ratio currently stands at 8.82, an important part of Global Health Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 8.82
• 2023: 10.95
• 2022: 5.08
• 2021: 0

A stable or declining Global Health Ltd P/S ratio indicates cautious market sentiment.

Global Health Ltd Price to Cash Flow Ratio (P/CF)

The Global Health Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 48.35.

Historical Global Health Ltd Price to Cash Flow Ratio:

• 2024: 48.35
• 2023: 55.57
• 2022: 22.12
• 2021: 0
• 2020: 0

The declining Global Health Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Global Health Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Global Health Ltd EV currently stands at ₹317.81B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 317.81B
• 2023: 351.82B
• 2022: 134.95B
• 2021: 0

Global Health Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Global Health Ltd EV/EBITDA ratio is currently 37.14, a key metric in Global Health Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 37.14
• 2023: 42.50
• 2022: 21.01
• 2021: 0

Stable Global Health Ltd EV/EBITDA indicates balanced valuation.

Global Health Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Global Health Ltd D/E ratio is currently 0.21, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.21
• 2023: 0.28
• 2022: 0.46
• 2021: 0.69

Global Health Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Global Health Ltd ROE currently stands at 15.30%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 15.30
• 2023: 17.93
• 2022: 16.13
• 2021: 13.09

Global Health Ltd maintains stable profitability levels.

Global Health Ltd Ratios Analysis Summary

The Global Health Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Global Health Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Global Health Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.